[1] Dienstag JL. Hepatitis C:a bitter harvest. Ann Intern, Med, 2006,144:770-771.
[2] Menconi F, Hasham A, Tomer Y. Environmental triggers of thyroiditis: hepatitis C and interferon-a. J Endocrinol Invest, 2011,34:78-84.
[3] 杨宗国,叶佩燕,陈晓蓉,等. 聚乙二醇干扰素联合利巴韦林治疗慢性丙型肝炎初治和再治患者的回顾性研究.中华全科医师杂志,2012,11:836-839.
[4] Caraccio N, Cuccato S, Pratesi F, et al. Effect of type I interferon-(s) on cell viability and apoptosis in primary human thyrocyte cultures. Thyroid,2009,19:149-155.
[5] Andrade LJ, Atta Am, D’Almeida Junior A, et al. Thyroid dysfunction in hepatitis C individuals treated with interferon -alpha and ribavirin-a review. Braz J Infect Dis, 2008,12:144-148. |
